Literature DB >> 3913378

Diclofenac versus indomethacin given as intravenous infusions: their effect on haemodynamics and bleeding time, and side-effects in healthy subjects.

M Rorarius, J Miralles, G A Baer, E Palomäki.   

Abstract

Given as an intravenous infusion during a 1-hour period, 32.5 mg diclofenac and 25 mg indomethacin did not cause significant changes in blood pressure or pulse rate in 31 healthy subjects. One hour after the end of the infusion, the bleeding time was significantly prolonged with both drugs; however, the mean values were within the normal range. There was no difference in the type of side-effects recorded in this study when compared to previous reports, except for a centrally stimulating effect of diclofenac, which appeared in 11 subjects. Diclofenac and indomethacin thus seem suitable for a patient study of pre-, intra- and postoperative treatment of pain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913378

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  6 in total

1.  Suppository diclofenac instead of intravenous meperidine for postoperative management.

Authors:  Ebrahim Alijanpour; Ali Jabbari; Seyed Mozaffar Rabiea; Shabnam Tabasi
Journal:  Caspian J Intern Med       Date:  2012

Review 2.  Side Effects of Indomethacin in Refractory Post-traumatic Intracranial Hypertension: A comprehensive case study and review.

Authors:  Daniel Agustín Godoy; Pablo David Guerrero Suarez; Luis Rafael Moscote-Salazar; Mario Di Napoli
Journal:  Bull Emerg Trauma       Date:  2017-07

3.  Pharmacokinetics of intravenous diclofenac sodium in children.

Authors:  R Korpela; K T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Intravenous ketorolac vs diclofenac for analgesia after maxillofacial surgery.

Authors:  P Tarkkila; M Tuominen; P H Rosenberg
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

Review 5.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 6.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.